ENZO BIOCHEM INC (ENZ) Top Institutional Shareholders
ENZO BIOCHEM INC (ENZ) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2025. The institutional investors covered on this page collectively reported approximately $2,072 in ENZ holdings during the latest filing period.
Medallion Wealth Advisors, Llc is currently the largest disclosed institutional shareholder of ENZ tracked by InsiderSet, reporting ownership valued at approximately $2,072 in its June 30, 2025 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed ENZ value among the investors covered in this analysis. Major shareholders include Medallion Wealth Advisors, Llc, and several other long-term asset managers with concentrated positions in ENZO BIOCHEM INC (ENZ).
This page ranks the largest institutional ENZ shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
1
Total Reported Value
$2,072
Largest Holder
Medallion Wealth Advisors, Llc
Largest Position
$2,072
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2025
New Institutional Positions
4
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Medallion Wealth Advisors, Llc | 0.00% | 5,600 | $2,072 | — | — | — |
Frequently asked questions about ENZ
Who owns the most ENZ stock?
The largest holders of ENZ are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ENZO BIOCHEM INC (ENZ).
Is ENZ widely held by superinvestors?
Many widely followed stocks like ENZ appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ENZ is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.